You just read:

BioDelivery Sciences Announces Acceptance of an Abstract to the International Conference on Opioids on the Impact of a State Formulary Conversion to BUNAVAIL

News provided by

BioDelivery Sciences International, Inc.

Apr 29, 2016, 07:00 ET